Giorgio Frega

Istituto Ortopedico Rizzoli

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Alessandro Rizzo

ITALY

View details

Claudio Agostinelli

Associate Professor of Pathology

University of Bologna

ITALY

View details

Davide Melisi

Assistant Professor of Medical Oncology

Università degli Studi di Torino

ITALY

View details

Alessio Giuseppe Morganti

ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA

ITALY

View details

Marco Gambarotti

IRCCS Istituto Ortopedico Rizzoli

ITALY

View details

Andrea De Giglio

University of Bologna

ITALY

View details

Valeria Merz

University of Verona

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Giorgio Frega

Research Interests

Explore related searches

Contact this professor

Articles (10)

Tumor Immune Microenvironment–Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial

Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications

The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma

Myoepithelial carcinoma of soft tissues and bone

Can repeated surgical resection offer a chance of cure for recurrent cholangiocarcinoma?

Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study

Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes

Intensive Follow-Up Program and Oncological Outcomes of Biliary Tract Cancer Patients after Curative-Intent Surgery: A Twenty-Year Experience in a Single Tertiary Medical Center

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study

Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis

Collaborators (7)

Alessandro Rizzo

Claudio Agostinelli

Davide Melisi

Alessio Giuseppe Morganti

Marco Gambarotti

Andrea De Giglio

Valeria Merz

Make your next move.